Academia
On this page, you will find information on the European Medicines Agency’s (EMA) activities that are most relevant to academia, including news and events.
Learn more about the Agency's resources to support medicine development:
Learn more about how EMA interacts with academia.
Featured information for academics and researchers
EMA joins EU Partnership on Animal Health and Welfare
EMA has become an associate of the EU Partnership on Animal Health and Welfare, established to help control infectious diseases of both terrestrial and aquatic animals. This partnership also aims to support the global One Health initiative. In this capacity, EMA will strengthen links between research and EU medicines regulation through communication and engagement with researchers and other stakeholders.
Public consultation for revised EMA-HMA guidance on commercially confidential information and personal data
EMA and the Heads of Medicines Agencies (HMA) are inviting academia representatives to comment on their revised draft guidance on protecting personal data and commercially confidential information from marketing authorisation applications for human medicines. The proposed revision includes updates to the scope and methodology for protecting this type of data, reflecting current EU and national laws. The deadline for comments is 28 June 2024.
Call for clinical-oncology scientists to join EMA / HMA pilot on participation in medicine regulation
EMA and HMA are inviting clinical-oncology and haemato-oncology scientists to apply for a pilot project aiming to develop their expertise in human medicine regulation. The pilot offers free webinars providing an understanding of the basic principles for this field. Participation is possible until May 2024.
Engaging with academia: action plan for 2021 to 2023
EMA's academia collaboration matrix action plan sets out how EMA intends to create closer ties with academics and researchers in the next two and a half years. It lists actions in five areas: regulatory science and partnerships, innovation and support to academia, communication, events strategy, and training.
Latest news
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.
NewsVeterinaryMedicines
EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its April 2024 meeting.
NewsHumanCOVID-19Medicines
Report on COVID-19 vaccine strain updates: global regulators agree on timing and data requirements
NewsHumanMedicinesVaccines
GLP-1 receptor agonists: available evidence not supporting link with suicidal and self-injurious thoughts and actions
NewsHumanMedicinesPharmacovigilanceReferrals
Publications of interest
EMA's 2022 annual report
Navigate through the digital report to view interviews, short videos and an interactive timeline of the Agency’s main activities in 2022. Read the traditional PDF version to see additional figures and statistics on EMA's regulatory procedures and activities.
Video: Working for every patient in Europe
Watch our short video for a quick and easy explanation of who EMA is and what it does. (video in English, with subtitles in 24 different languages).